logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

WUXI BIO (02269): Miao Jingwen appointed as non-executive director.

date
19:26 20/11/2024
avatar
GMT Eight
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
New stock news | Siasun Robot&Automation applies to the Hong Kong Stock Exchange again, as the leading provider of industrial intelligent mobile solutions in China for Siasun Robot&Automation.
New stock news | Wanheng Energy submits application to Hong Kong Stock Exchange
HK Stock
SKB BIO-B (06990): The application for clinical trial of ITGB6 ADC SKB105 new drug has been approved by the National Medical Products Administration.
New stock news | Siasun Robot&Automation applies to the Hong Kong Stock Exchange again, as the leading provider of industrial intelligent mobile solutions in China for Siasun Robot&Automation.
New stock news | Wanheng Energy submits application to Hong Kong Stock Exchange
SKB BIO-B (06990): The application for clinical trial of ITGB6 ADC SKB105 new drug has been approved by the National Medical Products Administration.
HK Stock
RECOMMEND
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
icon
29/12/2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
icon
29/12/2025
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
icon
29/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.